Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Breast 1

Conditions

Polycystic Ovary Syndrome 5Weight Loss 3Obesity 3Overweight 2Obesity, Abdominal 1Moderately Overweight Individuals 1Metabolic Syndrome 1Metabolic Diseases 1Menstruation Disturbances 1Intermittent Fasting 1Insulin Resistance 1Glucocorticoid Receptor Deficiency 1Fasting 1Breast Neoplasms 1Breast Cancer Female 1

Interventions

Exercise 4Counseling 3Nutrition Assessment 2Naltrexone 2Metformin 2Exenatide 2Diet 2Cognitive Behavioral Therapy 2Caloric Restriction 2Bupropion 2sultamicillin 1licogliflozin 1drospirenone and ethinyl estradiol combination 1drospirenone 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Sugars 1Sucrose 1Standard of Care 1Resistance Training 1Psychology, Positive 1Propofol 1Motivational Interviewing 1Mindfulness-Based Stress Reduction 1Methods 1Flutamide 1Ethinyl Estradiol 1Diet, Mediterranean 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Overweight × Caloric Restriction × Clear all
NCT05629858 2025-03-13

Time Restricted Eating for the Treatment of PCOS

University of Illinois at Chicago

Phase NA Completed
76 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Overweight

NCT02940470 2018-08-03

Weight Loss Pilot Study in Postmenopausal Breast Cancer Survivors

USDA Grand Forks Human Nutrition Research Center

Phase NA Completed
22 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡